We have synthesized novel glutathione (GSH) responsive silica nanoparticles by introducing disulfide bonds into silica nanoparticles, which are highly uniform in size and show excellent blood compatibility. The subsequent degradation process under physiological conditions shows their promising potential for medical treatment and diagnosis.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: